References
- Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008;111:2505–2515.
- de la Serna J, Montesinos P, Vellenga E, et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 2008;111:3395–3402.
- Frankel SR, Eardley A, Lauwers G, et al. The retinoic acid syndrome in acute promyelocytic leukemia. Ann Intern Med. 1992;117:292–296.
- Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106:447–453.
- Sanz MA, Montesinos P, Rayon C, et al. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood. 2010;115:5137–5146.
- Soignet SL, Frankel SR, Douer D, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol. 2001;19:3852–3860.
- Montesinos P, Bergua JM, Vellenga E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009;113:775–783.
- Sanz MA, Tallman MS, Lo-Coco F. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood. 2005;105:3019–3025.
- Kakkar N, Dhameja N, Jasmina, et al. ATRA syndrome with extensive organ infiltration. Am J Hematol. 2002;71:62–64.
- Fabbiano F, Magrin S, Cangialosi C, et al. All-trans retinoic acid induced cardiac and skeletal myositis in induction therapy of acute promyelocytic leukaemia. Br J Haematol. 2005;129:444–445.
- Klein SK, Biemond BJ, van Oers MH. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA). Ann Hematol. 2007;86:917–918.
- Manna A, Cadenotti L, Motto A, et al. Reversible cardiac dysfunction without myocytolysis related to all-trans retinoic acid administration during induction therapy of acute promyelocytic leukemia. Ann Hematol. 2009;88:91–92.
- van Rijssel RH, Wegman J, Oud ME, et al. A case of ATRA-induced isolated myocarditis in the absence of circulating malignant cells: demonstration of the t(15;17) translocation in the inflammatory infiltrate by in situ hybridisation. Leuk Res. 2010;34:e142–e144.
- Isik P, Cetin I, Tavil B, et al. All-transretinoic acid (ATRA) treatment-related pancarditis and severe pulmonary edema in a child with acute promyelocytic leukemia. J Pediatr Hematol Oncol. 2010;32:e346–e348.
- Choi S, Kim HS, Jung CS, et al. Reversible symptomatic myocarditis induced by all-trans retinoic acid administration during induction treatment of acute promyelocytic leukemia: rare cardiac manifestation as a retinoic acid syndrome. J Cardiovasc Ultrasound. 2011;19:95–98.